Abstract:Chronic inflammation plays a crucial role in the onset and progression of pathologies like neurodegenerative and cardiovascular diseases, diabetes, and cancer, since tumor development and chronic inflammation are linked, sharing common signaling pathways. At least 20% of breast and colorectal cancers are associated with chronic inflammation triggered by infections, irritants, or autoimmune diseases. Obesity, chronic inflammation, and cancer interconnection underscore the importance of population-based interventions in maintaining healthy body weight, to disrupt this axis. Given that the dietary inflammatory index is correlated with an increased risk of cancer, adopting an anti-inflammatory diet supplemented with nutraceuticals may be useful for cancer prevention. Natural products and their derivatives offer promising antitumor activity with favorable adverse effect profiles; however, the development of natural bioactive drugs is challenging due to their variability and complexity, requiring rigorous research processes. It has been shown that combining anti-inflammatory products, such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and statins, with plant-derived products demonstrate clinical utility as accessible adjuvants to traditional therapeutic approaches, with known safety profiles. Pharmacological approaches targeting multiple proteins involved in inflammation and cancer pathogenesis emerge as a particularly promising option. Given the systemic and multifactorial nature of inflammation, comprehensive strategies are essential for long term success in cancer therapy. To gain insights into carcinogenic phenomena and discover diagnostic or clinically relevant biomarkers, is pivotal to understand genetic variability, environmental exposure, dietary habits, and TME composition, to establish therapeutic approaches based on molecular and genetic analysis. Furthermore, the use of endocannabinoid, cannabinoid, and prostamide-type compounds as potential therapeutic targets or biomarkers requires further investigation. This review aims to elucidate the role of specific etiological agents and mediators contributing to persistent inflammatory reactions in tumor development. It explores potential therapeutic strategies for cancer treatment, emphasizing the urgent need for cost-effective approaches to address cancer-associated inflammation.

Metabolic Syndrome, Inflammation, and Cancer

The Role of Aberrant Metabolism in Cancer: Insights into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer

Metabolic Syndrome, Inflammation, and Cancer

Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer and metastasis

New Study Progress on the Relationship between Metabolic Syndrome and Cancer

Metabolic Syndrome And Breast Cancer: Prevalence, Treatment Response, And Prognosis

Associations between "Cancer Risk", "Inflammation" and "Metabolic Syndrome": A Scoping Review

From Inflammation to Cancer: the Molecular Basis

Lymphatic system: a vital link between metabolic syndrome and inflammation

Metabolic regulation in the immune response to cancer

Clinical and genomic characteristics of metabolic syndrome in colorectal cancer

The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer

Research advances in the therapy of metabolic syndrome

Chemotherapy and Metabolic Syndrome: A Comprehensive Review of Molecular Pathways and Clinical Outcomes

Inflammation and cancer: friend or foe?

Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis

The role of dietary inflammatory index in metabolic diseases: the associations, mechanisms, and treatments

Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes

Temporal relationship between inflammation and metabolic disorders and their impact on cancer risk

Metabolic Inflammation and Insulin Resistance in Obesity

Macrophages and T cells in metabolic disorder-associated cancers